Palazzo, R.; Stefanantoni, K.; Cadar, M.; Butera, A.; Riccieri, V.; Lande, R.; Frasca, L.
Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort. Antibodies 2022, 11, 77.
https://doi.org/10.3390/antib11040077
AMA Style
Palazzo R, Stefanantoni K, Cadar M, Butera A, Riccieri V, Lande R, Frasca L.
Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort. Antibodies. 2022; 11(4):77.
https://doi.org/10.3390/antib11040077
Chicago/Turabian Style
Palazzo, Raffaella, Katia Stefanantoni, Marius Cadar, Alessia Butera, Valeria Riccieri, Roberto Lande, and Loredana Frasca.
2022. "Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort" Antibodies 11, no. 4: 77.
https://doi.org/10.3390/antib11040077
APA Style
Palazzo, R., Stefanantoni, K., Cadar, M., Butera, A., Riccieri, V., Lande, R., & Frasca, L.
(2022). Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort. Antibodies, 11(4), 77.
https://doi.org/10.3390/antib11040077